The company in question is, Johnson & Johnson (NYSE:JNJ) currently with a stock price of 133.45 (0.31% today). The market cap for Johnson & Johnson is 358.94 B, and is in the sector Healthcare, and Drug Manufacturers – Major industry. The target price for Johnson & Johnson is 130.28. Currently Johnson & Johnson is trading with a P/E of 22.36, and a forward P/E of 17.34. Average volume for Johnson & Johnson is 5809.2 and so far today it is 330.
Performance in the last year for Johnson & Johnson has been 14.29%. For EPS growth, Johnson & Johnson has seen a growth of 8.30%, and is looking to grow in the next year to 7.99%. More long term stats show that EPS growth has been 11.20% over the last five years and could be 6.45% for the next five years. Johnson & Johnson has seen sales growth quarter over quarter at 1.60%, with EPS growth quarter over quarter at 1.00%. The 20-day simple moving average is 3.11%, with the 200-day simple moving average coming to 11.34%.
Since the IPO date for Johnson & Johnson on the 01/02/1970, Johnson & Johnson has seen performance year to date to be 15.48%. With Johnson & Johnson trading at 133.45, the dividend yield is 2.53%, and the EPS is 5.95.
So could Johnson & Johnson, be undervalued? Well as said before P/E is 22.36. The PEG is 3.47, P/S is 4.97 and the P/B is at 5.12. The P/cash is 9.12, with P/free cash flow at 41.9.
Johnson & Johnson ability to deal with debt shows that the current ratio is 2.5, and the quick ratio is 2.2. This is with long term debt/equity at 0.38, and total debt/equity at 0.46.
In terms of margins, Johnson & Johnson has a gross margin of 69.90%, an operating margin of 27.80% and a profit margin of 22.90%.Payout ratio for Johnson & Johnson is 52.80%. Return on assets come to 11.70% with return on investment coming to 17.00%.
Insider ownership for Johnson & Johnson, is at 0.02% and institutional ownership comes to 67.90%. Outstanding shares are at 2697.96. While shares float is 2692.58. The float short is currently 0.59%, and short ratio is 2.75.
Graphs: Johnson & Johnson NYSE: JNJ | Friday June 16, 2017
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.